Skip to main content
. 2022 May 6;81(6):414–433. doi: 10.1093/jnen/nlac028

TABLE 3.

Summary of Effects of Azetidine Exposure in Adult and Neonatal Mice

Experiment Clinical Disease (600 mg/kg group only) OL Nucleomegaly and Nuclear Clearing (LM, EM) OL Apoptosis (TUNEL, Caspase-3 IHC) WM Microglial Reaction/Nodules (Iba-1 IHC) OL ER stress/UPR
↑MHC 1 on Apoptotic OL (IHC) WM Myelin Blistering and Myelinosomes (MBP IHC) Dystrophic WM Axons (LM, Biel) Liver Abnormalities (LM)
Nuclear translocation of UPR proteins (IHC) Dilated ER, autophagy/mitophagy (EM)
A1 (adult mice) + + + + + + + + +
A2 (adult mice) + ND + ND + ND ND ND +
N1 pups* + ND ND ND ND ND ND ND +
N1 dams* + ND ND ND ND ND ND ND +
N2 pups + +§ ND ND ND + ND ND +
N2 dams + + ND ND ND ND ND +

Biel, Bielschowsky silver impregnation; EM, electron microscopy; ER, endoplasmic reticulum; IHC, immunohistochemistry; LM, light microscopy; MBP, myelin basic protein; ND, not done; OL, oligodendrocyte; UPR, unfolded protein response; WM, white matter; +, present; −, analysis performed with negative results.

*

Treatment PO-initiated postweaning with 350 mg/kg Aze resulted in no definite effects on the CNS by routine LM analysis.

Aze dose-dependent effects.

Increased frequency in pups with longer exposures to Aze.

§

Greater incidence of OL apoptosis in Aze-treated pups versus dams.